Unbound MEDLINE

JAK2 Gets Histone H3 Rolling. Cancer cell [Cancer Cell] Journal article

 
TitleJAK2 Gets Histone H3 Rolling.
Author(s)Sattler M, Griffin JD 
InstitutionDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
SourceCancer Cell 2009 Nov 6; 16(5):365-6.
AbstractActivation of JAK2 is implicated in normal hematopoiesis as well as oncogenic transformation. A paper in the recent issue of Nature demonstrates that phosphorylation of histone H3 by JAK2 releases the transcriptional repressor HP1alpha from chromatin, resulting in gene transcription.
Languageeng
Pub Type(s)Journal Article
PubMed ID19878867
  
Advertise on this site.